Gene expression patterns following unilateral traumatic brain injury reveals a local pro-inflammatory and remote anti-inflammatory response

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  White, Todd E ^a   Ford, Gregory D ^b   Surles Zeigler, Monique C ^a   Gates, Alicia S ^a   LaPlaca, Michelle C ^c   Ford, Byron D ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b MOREHOUSE COLLEGE   (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Bioinformatics; Cytokine; Gene interaction hierarchy; Inflammation; Microarray; Rat; Traumatic brain injury

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; COLLAGENASE 3; COLONY STIMULATING FACTOR 1; CXCL1 CHEMOKINE; CXCL13 CHEMOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE B; HLA C ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN 1BETA; INTERLEUKIN 6; JANUS KINASE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OSTEOPONTIN; PROTEIN FOS; STAT PROTEIN; STAT3 PROTEIN; STROMELYSIN; THROMBOMODULIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOINFORMATICS; BRAIN TISSUE; CBL GENE; CCND1 GENE; CD44 GENE; CEBPD GENE; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE MODEL; DRUG TARGETING; EGFR GENE; ERAP1 GENE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; HISTOPATHOLOGY; IL6ST GENE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; ITGA5 GENE; LYN GENE; MICROARRAY ANALYSIS; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; RAT; SDC1 GENE; SIGNAL TRANSDUCTION; SPP1 GENE; STAT3 GENE; THRA GENE; TIMP1 GENE; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; INFLAMMATION; MALE; PRINCIPAL COMPONENT ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84876960507     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-282     Document Type: Article

References (40)

1. Zaloshnja E, Miller T, Langlois JA, Selassie AW. Prevalence of long-term disability from traumatic brain injury in the civilian population of the United States, 2005. J Head Trauma Rehabil 2008, 23(6):394-400. 10.1097/01.HTR.0000341435.52004.ac, 19033832.
2. Faul M, Xu L, Wald MM, Coronado VG. Traumatic brain injury in the United States: emergency department visits, hospitalizations and deaths 2002-2006 2010, Atlanta (GA): Centers for Disease Control and Prevention, National Center for Injury Prevention and Control.
3. Coronado VG, Xu L, Basavaraju SV, McGuire LC, Wald MM, Faul MD, Guzman BR, Hemphill JD. Surveillance for traumatic brain injury-related deaths-United States, 1997-2007. MMWR Surveill Summ 2011, 60(5):1-32.
4. Selassie AW, Zaloshnja E, Langlois JA, Miller T, Jones P, Steiner C. Incidence of long-term disability following traumatic brain injury hospitalization, United States, 2003. J Head Trauma Rehabil 2008, 23(2):123-131. 10.1097/01.HTR.0000314531.30401.39, 18362766.
5. McIntosh TK, Saatman KE, Raghupathi R, Graham DI, Smith DH, Lee VM, Trojanowski JQ. The Dorothy Russell Memorial Lecture. The molecular and cellular sequelae of experimental traumatic brain injury: pathogenetic mechanisms. Neuropathol Appl Neurobiol 1998, 24(4):251-267. 10.1046/j.1365-2990.1998.00121.x, 9775390.
6. Bramlett HM, Dietrich WD. Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J Cereb Blood Flow Metab 2004, 24(2):133-150.
7. Loane DJ, Faden AI. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci 2010, 31(12):596-604. 10.1016/j.tips.2010.09.005, 2999630, 21035878.
8. Ingenuity® Systems Web Site. http://www.ingenuity.com.
9. Morganti-Kossmann MC, Rancan M, Stahel PF, Kossmann T. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care 2002, 8(2):101-105. 10.1097/00075198-200204000-00002, 12386508.
10. Ghirnikar RS, Lee YL, Eng LF. Inflammation in traumatic brain injury: role of cytokines and chemokines. Neurochem Res 1998, 23(3):329-340. 10.1023/A:1022453332560, 9482245.
11. IPA® Canonical Pathways Overview. http://ingenuity.force.com/ipa/IPATutorials?id=kA250000000TN3aCAG.
12. Fan L, Young PR, Barone FC, Feuerstein GZ, Smith DH, McIntosh TK. Experimental brain injury induces expression of interleukin-1[beta] mRNA in the rat brain. Brain Res Mol Brain Res 1995, 30(1):125-130. 10.1016/0169-328X(94)00287-O, 7609633.
13. Rostworowski M, Balasingam V, Chabot S, Owens T, Yong VW. Astrogliosis in the neonatal and adult murine brain post-trauma: elevation of inflammatory cytokines and the lack of requirement for endogenous interferon-gamma. J Neurosci 1997, 17(10):3664-3674.
14. Shojo H, Kaneko Y, Mabuchi T, Kibayashi K, Adachi N, Borlongan CV. Genetic and histologic evidence implicates role of inflammation in traumatic brain injury-induced apoptosis in the rat cerebral cortex following moderate fluid percussion injury. Neuroscience 2010, 171(4):1273-1282. 10.1016/j.neuroscience.2010.10.018, 20950674.
15. Hang CH, Shi JX, Tian J, Li JS, Wu W, Yin HX. Effect of systemic LPS injection on cortical NF-kappaB activity and inflammatory response following traumatic brain injury in rats. Brain Res 2004, 1026(1):23-32. 10.1016/j.brainres.2004.07.090, 15476694.
16. IPA® Network Generation. http://ingenuity.force.com/ipa/IPATutorials?id=kA250000000TNBZCA4.
17. Ford G, Xu Z, Gates A, Jiang J, Ford BD. Expression Analysis Systematic Explorer (EASE) analysis reveals differential gene expression in permanent and transient focal stroke rat models. Brain Res 2006, 1071(1):226-236. 10.1016/j.brainres.2005.11.090, 16409990.
18. Xu Z, Ford GD, Croslan DR, Jiang J, Gates A, Allen R, Ford BD. Neuroprotection by neuregulin-1 following focal stroke is associated with the attenuation of ischemia-induced pro-inflammatory and stress gene expression. Neurobiol Dis 2005, 19(3):461-470. 10.1016/j.nbd.2005.01.027, 16023588.
19. Xu Z, Jiang J, Ford G, Ford BD. Neuregulin-1 is neuroprotective and attenuates inflammatory responses induced by ischemic stroke. Biochem Biophys Res Commun 2004, 322(2):440-446. 10.1016/j.bbrc.2004.07.149, 15325249.
20. Li Y, Lein PJ, Liu C, Bruun DA, Tewolde T, Ford G, Ford BD. Spatiotemporal pattern of neuronal injury induced by DFP in rats: a model for delayed neuronal cell death following acute OP intoxication. Toxicol Appl Pharmacol 2011, 253(3):261-269. 10.1016/j.taap.2011.03.026, 3108263, 21513723.
21. Israelsson C, Bengtsson H, Kylberg A, Kullander K, Lewen A, Hillered L, Ebendal T. Distinct cellular patterns of upregulated chemokine expression supporting a prominent inflammatory role in traumatic brain injury. J Neurotrauma 2008, 25(8):959-974. 10.1089/neu.2008.0562, 18665806.
22. Chavarria A, Alcocer-Varela J. Is damage in central nervous system due to inflammation?. Autoimmun Rev 2004, 3(4):251-260. 10.1016/j.autrev.2003.09.006, 15246020.
23. Laird MD, Vender JR, Dhandapani KM. Opposing roles for reactive astrocytes following traumatic brain injury. Neurosignals 2008, 16(2-3):154-164.
24. Di Pietro V, Amin D, Pernagallo S, Lazzarino G, Tavazzi B, Vagnozzi R, Pringle A, Belli A. Transcriptomics of traumatic brain injury: gene expression and molecular pathways of different grades of insult in a rat organotypic hippocampal culture model. J Neurotrauma 2010, 27(2):349-359. 10.1089/neu.2009.1095, 19903084.
25. Herx LM, Rivest S, Yong VW. Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor. J Immunol 2000, 165(4):2232-2239.
26. Kochanek PM, Berger RP, Bayir H, Wagner AK, Jenkins LW, Clark RS. Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Curr Opin Crit Care 2008, 14(2):135-141. 10.1097/MCC.0b013e3282f57564, 18388674.
27. Khan M, Im YB, Shunmugavel A, Gilg AG, Dhindsa RK, Singh AK, Singh I. Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact. J Neuroinflammation 2009, 6:32. 10.1186/1742-2094-6-32, 2777134, 19889224.
28. Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol 2007, 184(1-2):53-68. 1868538, 17188755.
29. Kong Y, Le Y. Toll-like receptors in inflammation of the central nervous system. Int Immunopharmacol 2011, 11(10):1407-1414. 10.1016/j.intimp.2011.04.025, 21600311.
30. Rall JM, Matzilevich DA, Dash PK. Comparative analysis of mRNA levels in the frontal cortex and the hippocampus in the basal state and in response to experimental brain injury. Neuropathol Appl Neurobiol 2003, 29(2):118-131. 10.1046/j.1365-2990.2003.00439.x, 12662320.
31. Fahlenkamp AV, Coburn M, Czaplik M, Ryang YM, Kipp M, Rossaint R, Beyer C. Expression analysis of the early chemokine response 4 h after in vitro traumatic brain injury. Inflamm Res 2011, 60(4):379-387. 10.1007/s00011-010-0281-6, 21104293.
32. von Gertten C, Flores MA, Holmin S, Mathiesen T, Nordqvist AC. Genomic responses in rat cerebral cortex after traumatic brain injury. BMC Neurosci 2005, 6:69. 10.1186/1471-2202-6-69, 1310614, 16318630.
33. Kobori N, Clifton GL, Dash P. Altered expression of novel genes in the cerebral cortex following experimental brain injury. Brain Res Mol Brain Res 2002, 104(2):148-158. 10.1016/S0169-328X(02)00331-5, 12225869.
34. Poulsen CB, Penkowa M, Borup R, Nielsen FC, Caceres M, Quintana A, Molinero A, Carrasco J, Giralt M, Hidalgo J. Brain response to traumatic brain injury in wild-type and interleukin-6 knockout mice: a microarray analysis. J Neurochem 2005, 92(2):417-432. 10.1111/j.1471-4159.2004.02877.x, 15663489.
35. Ley EJ, Clond MA, Singer MB, Shouhed D, Salim A. IL6 deficiency affects function after traumatic brain injury. J Surg Res 2011, 170(2):253-256. 10.1016/j.jss.2011.03.006, 21529825.
36. Clausen F, Hanell A, Bjork M, Hillered L, Mir AK, Gram H, Marklund N. Neutralization of interleukin-1beta modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice. Eur J Neurosci 2009, 30(3):385-396. 10.1111/j.1460-9568.2009.06820.x, 19614750.
37. Feuerstein GZ, Wang X, Barone FC. Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets. Ann N Y Acad Sci 1997, 825:179-193. 10.1111/j.1749-6632.1997.tb48428.x, 9369986.
38. Li HH, Lee SM, Cai Y, Sutton RL, Hovda DA. Differential gene expression in hippocampus following experimental brain trauma reveals distinct features of moderate and severe injuries. J Neurotrauma 2004, 21(9):1141-1153.
39. Affymetrix GeneChip® 3 ′ IVT Express Kit User Manual. vol. P/N 702646 Rev. 8 2010, http://www.affymetrix.com/support/technical/manuals.affx, Affymetrix.
40. Sturn A, Quackenbush J, Trajanoski Z. Genesis: cluster analysis of microarray data. Bioinformatics 2002, 18(1):207-208. 10.1093/bioinformatics/18.1.207, 11836235.